Dyno could receive up to $1.8bn in collaboration-associated payments

Review draws on experiences of patients and expert consensus

DNA maker Touchlight adds Lonza manufacturing vet as it swings at COVID-19 vaccine, cell and gene therapy markets […]

Drug is licensed for secondary progressive multiple sclerosis with active disease

Primes company to submit vaccine candidate for rolling review

Updated Date: Wed, 07 Oct 2020 00:00:00 EDT

Updated Date: Wed, 07 Oct 2020 00:00:00 EDT

Updated Date: Wed, 07 Oct 2020 00:00:00 EDT

Updated Date: Wed, 07 Oct 2020 00:00:00 EDT

Updated Date: Wed, 07 Oct 2020 00:00:00 EDT